Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ARM

In Brief - Series (ARM) Stock

Shares of Technology sector company Series moved -4.5% today, and are now trading at a price of $135.15. The Large-Cap stock's daily volume was 3,035,548 compared to its average volume of 4,565,304. The S&P 500 index returned a 0.0% performance.

Arm Holdings plc architects, develops, and licenses central processing unit products and related technologies for semiconductor companies and original equipment manufacturers. The company is based in Cambridge and has 8,330 full time employees. Its market capitalization is $143,393,947,648.

32 analysts are following Series and have set target prices ranging from $80.0 to $215.0 per share. On average, they have given the company a rating of buy. At today's prices, ARM is trading -19.54% away from its average analyst target price of $167.97 per share.

Over the last year, ARM shares have gone down by -4.4%, which represents a difference of -18.2% when compared to the S&P 500. The stock's 52 week high is $183.16 per share and its 52 week low is $80.0. Although Series's average free cash flow over the last 3 years has been $180.5 Million, they have been decreasing at an average rate of -13.5%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 397,000 219,000 178,000 3066.67
2023 139,000 145,000 -6,000 -101.75
2022 423,000 81,000 342,000 64.42
2021 256,000 48,000 208,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS